CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Technological advancements such as automation of liquid handling
4.1.2. Creation of novel technological platforms
4.1.3. Development of analytical tools to deal with massive quantities of data
4.1.4. Government funding and venture capital investments
4.2. Market Restraints & Challenges
4.2.1. Complexities in the field of assay development
4.2.2. The dearth of skilled operators
4.3. Market Opportunities
4.3.1. Growing research activities in toxicology and stem cells
4.3.2. Emerging markets
CHAPTER 5. GLOBAL HIGH THROUGHPUT SCREENING MARKET – BY
PRODUCT & SERVICES
5.1. Reagents & Assay Kits
5.2. Instruments
5.3. Consumables & Accessories
5.4. Software
5.5. Services
CHAPTER 6. GLOBAL HIGH THROUGHPUT SCREENING MARKET – BY
TECHNOLOGY
6.1. Cell-Based Assays
6.2.1. 2D Cell Culture
6.2.2. 3D Cell Culture
6.1.2.1. Scaffold-Based Technology
6.1.2.1.1. Hydrogels
6.1.2.1.1.1. Animal-Derived Hydrogels
6.1.2.1.1.1.1. Matrigel
6.1.2.1.1.1.2. Collagen
6.1.2.1.1.2. Synthetic Hydrogels
6.1.2.1.1.3. Alginate/Agarose
6.1.2.1.2. Inert Matrix/Solid Scaffolds
6.1.2.1.3. Micropatterned Surfaces
6.2.2.2. Scaffold-Free Technology
6.1.2.2.1. Microplates
6.1.2.2.2. Hanging-Drop Plates
6.1.2.2.3. Ultra-Low Binding Plates
6.1.2.2.4. Other Scaffold-Free Technologies
6.1.3. Perfusion Cell Culture
6.2. Lab-On-A-Chip
6.3. Ultra-High-Throughput Screening
6.4. Bioinformatics
6.5. Label-Free Technology
CHAPTER 7. GLOBAL HIGH THROUGHPUT SCREENING MARKET – BY
APPLICATION
7.1. Target Identification and Validation
7.2. Primary and Secondary Screening
7.3. Toxicology Assessment
7.4. Others
CHAPTER 8. GLOBAL HIGH THROUGHPUT SCREENING MARKET – BY END
USER
8.1. Pharmaceutical and Biotechnology Companies
8.2. Academic and Government Institutes
8.3. Contract Research Organizations (CRO)
8.4. Others
CHAPTER 9. GLOBAL HIGH THROUGHPUT SCREENING MARKET - BY
GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL HIGH THROUGHPUT SCREENING MARKET -
COMPANY PROFILES
10.1. Axxam S.P.A.
10.2. Bio-Rad Laboratories
10.3. Merck Group
10.4. Hamilton Company
10.5. Corning Incorporated
10.6. Biotek Instruments
10.7. Aurora Biomed
10.8. Thermo Fisher Scientific Inc.
10.9 Agilent Technologies, Inc.
10.10 Danaher Corporation
10.11 Perkinelmer, Inc.
10.12 Tecan Group
10.13. Aurora Biomed
10.14. Sigma Aldrich Corporation
CHAPTER 11. GLOBAL HIGH THROUGHPUT SCREENING MARKET -
COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
